Oestrogen and progesterone receptors and disease-free interval in primary breast cancer
1984

Oestrogen and Progesterone Receptors in Breast Cancer

Sample size: 263 publication Evidence: low

Author Information

Author(s): A. Alanko, E. Heinonen, T.M. Scheinin, E.-M. Tolppanen, R. Vihko

Primary Institution: Helsinki University Central Hospital

Hypothesis

Is there a relationship between oestrogen and progesterone receptor status and disease-free interval in primary breast cancer?

Conclusion

The study found no significant relationship between oestrogen or progesterone receptor status and disease-free interval in breast cancer patients.

Supporting Evidence

  • 62.6% of patients were oestrogen receptor positive.
  • 62.9% of patients were progesterone receptor positive.
  • Only 1.9% of patients received postoperative endocrine treatment.

Takeaway

The study looked at women with breast cancer and found that having certain hormone receptors didn't help predict how long they would be free of disease after treatment.

Methodology

Receptor assays were performed on tumor samples from 286 women, with follow-up for at least 24 months.

Potential Biases

Potential bias due to the retrospective nature of some data and the influence of adjuvant treatments.

Limitations

The study had a small percentage of patients receiving adjuvant treatment, which may affect the results.

Participant Demographics

30% pre-menopausal and 70% postmenopausal women.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication